Daily News Podcast

Is it time to revise ASCVD cardiovascular risk threshold?


 

Researchers suggest that revising the threshold for high CV risk from 7.5% at 10 years to 10% at 10 years. Also today, psoriasis adds to risk of CV procedures and surgery in hypertension, sickle cell disease gene therapy seen advancing, and early appendectomy is linked with a reduction in risk for developing Parkinson’s later in life.

Amazon Alexa
Apple Podcasts
Spotify

Recommended Reading

HCV, HBV, and HIV associated with autoimmune kidney diseases
MDedge Rheumatology
Novel blood test for RA prevention?
MDedge Rheumatology
Screening for intimate partner violence
MDedge Rheumatology
Validation for SLE low-disease definition
MDedge Rheumatology
Heather Yeo: Surgical Residency Attrition
MDedge Rheumatology
AKI linked to later dementia
MDedge Rheumatology
Part B scheme raises concerns
MDedge Rheumatology
Palliative care update highlights role of nonspecialists
MDedge Rheumatology
NSAID risk score validated for CV events
MDedge Rheumatology
TENS improves fibromyalgia pain
MDedge Rheumatology